Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
Nabors Industries
NBR
$1.18B
| $522K | ﹤0.01% |
3,626
+1,424
| +65% | +$150K |
|
|
NVEE
4202
DELISTED
NV5 Global
NVEE
| $522K | ﹤0.01% |
41,420
+21,004
| +103% | +$306K |
|
4203
PUT
Perrigo
PRGO
$1.85B
| $522K | ﹤0.01% |
10,100
+6,100
| +153% | +$319K |
|
4204
Vodafone
VOD
$35.3B
| $522K | ﹤0.01% |
27,003
+14,796
| +121% | +$295K |
|
4205
CALL
Genworth Financial
GNW
$3.72B
| $521K | ﹤0.01% |
118,500
+34,700
| +41% | +$146K |
|
4206
CryoPort
CYRX
$771M
| $519K | ﹤0.01% |
31,515
+1,962
| +7% | +$29.2K |
|
4207
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$436M
| $517K | ﹤0.01% |
5,000
| – | – |
|
|
GNMK
4208
DELISTED
GenMark Diagnostics, Inc
GNMK
| $517K | ﹤0.01% |
107,516
+40,787
| +61% | +$225K |
|
|
PMBC
4209
DELISTED
Pacific Mercantile Bancorp
PMBC
| $516K | ﹤0.01% |
63,516
+53,648
| +544% | +$393K |
|
|
CIT
4210
PUT
DELISTED
CIT Group Inc.
CIT
| $516K | ﹤0.01% |
11,300
-52,700
| -82% | -$2.36M |
|
4211
Modine Manufacturing
MOD
$10.5B
| $514K | ﹤0.01% |
66,824
+7,105
| +12% | +$63.7K |
|
|
SABA
4212
Saba Capital Income & Opportunities Fund II
SABA
$224M
| $513K | ﹤0.01% |
41,834
| – | – |
|
|
MITT
4213
TPG Mortgage Investment Trust
MITT
$223M
| $512K | ﹤0.01% |
11,059
+5,289
| +92% | +$244K |
|
|
SOHU
4214
Sohu.com
SOHU
$362M
| $511K | ﹤0.01% |
45,765
-112,644
| -71% | -$1.18M |
|
4215
CALL
WisdomTree
WT
$3.45B
| $509K | ﹤0.01% |
105,200
-300
| -0.3% | -$1.49K |
|
4216
Financial Institutions
FISI
$840M
| $507K | ﹤0.01% |
15,767
+7,692
| +95% | +$242K |
|
4217
Live Oak Bancshares
LOB
$2.02B
| $507K | ﹤0.01% |
26,631
+13,579
| +104% | +$251K |
|
4218
Luxfer Holdings
LXFR
$457M
| $507K | ﹤0.01% |
27,414
+14,246
| +108% | +$245K |
|
|
STML
4219
DELISTED
Stemline Therapeutics, Inc.
STML
| $507K | ﹤0.01% |
47,691
+23,905
| +101% | +$237K |
|
|
MPVD
4220
DELISTED
Mountain Province Diamonds Inc.
MPVD
| $507K | ﹤0.01% |
570,966
| – | – |
|
4221
Sierra Bancorp
BSRR
$530M
| $506K | ﹤0.01% |
17,372
+10,159
| +141% | +$279K |
|
4222
CALL
Danaher
DHR
$140B
| $506K | ﹤0.01% |
3,722
-16,356
| -81% | -$2.07M |
|
4223
CALL
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
| $505K | ﹤0.01% |
7,200
+2,200
| +44% | +$150K |
|
4224
Goosehead Insurance
GSHD
$2.4B
| $504K | ﹤0.01% |
11,869
+6,042
| +104% | +$267K |
|
|
NSTG
4225
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $504K | ﹤0.01% |
18,100
-481,900
| -96% | -$11.7M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.